As of 2026-04-05, the Fair Value of Hainan Huluwa Pharmaceutical Group Co Ltd (605199.SS) is -4.62 CNY. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.77 CNY, the upside of Hainan Huluwa Pharmaceutical Group Co Ltd is -168.22%.
With the market price of 6.77 CNY and our fair value calculation, Hainan Huluwa Pharmaceutical Group Co Ltd (605199.SS) is not a good investment. Investing in 605199.SS stocks now will result in a potential loss of 168.22%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 121.50 | 72.14 | 85.68 | 10.85 | -274.46 | 3.14 |
| YoY growth | 1.00% | -40.63% | 18.78% | -87.34% | -2,629.23% | -547.48% |
| Market Cap (mil) | 2,708.74 |
| P/E | |
| Forward P/E |
| EPS | -0.92 |
| Avg earnings growth rate | -547.48% |
| TTM earnings | -369.56 |